RNU6-844P

Across TCGA pan-cancer cohorts, RNU6-844P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-844P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU6-844P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-844P expression acts as an unfavorable survival marker, although some lineages such as BRCA and OV show a favorable association.

BRCA, THCA, and READ are the cancer types where RNU6-844P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	II,III,IV	0.665	0.539	.002	55	view →
THCA	OS	Quartile	II,III,IV	0.611	0.976	.003	46	view →
READ	DFS	Tertile	III,IV	0.273	0.761	.011	45	view →
MESO	DFS	Tertile	III,IV	0.221	0.411	.003	36	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
ACC	DFS	Tertile	II,III,IV	0.287	0.656	.013	24	view →
KIRP	DFS	Tertile	III,IV	0.167	0.725	<.001	18	view →
LIHC	DFS	Tertile	II,III,IV	0.171	0.379	.004	11	view →
PCPG	OS	Tertile	All	0.539	0.954	.021	9	view →
KICH	OS	Median	All	0.760	1.000	.042	8	view →
KIRC	DFS	Quartile	IV	0.485	0.685	.028	6	view →
OV	OS	Tertile	IV	0.867	0.711	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-844P–BRCA (OS)

Open the BRCA breakdown →